Agree(ADC),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

ADC Agree

Not Yet Opened 04-21 16:00:00 EDT

78.72

-0.33

-0.42%

盘后78.72

+0.000.00%

19:20 EDT

High79.57	Low77.63	Vol1.07M
Open78.89	D1 Closing79.05	Amplitude2.45%
Mkt Cap8.43B	Tradable Cap8.27B	Total Shares107.13M
T/O83.80M	T/O Rate1.02%	Tradable Shares105.06M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

Invest in Global Markets with Tiger Brokers!

Open App

{"stockData":{"symbol":"ADC","market":"US","secType":"STK","nameCN":"Agree","latestPrice":78.72,"timestamp":1745265600000,"preClose":79.05,"halted":0,"volume":1068242,"hourTrading":{"tag":"盘后","latestPrice":78.72,"preClose":78.72,"latestTime":"19:20 EDT","volume":48608,"amount":3826415.71,"timestamp":1745277610225},"delay":0,"floatShares":105055332,"shares":107134634,"eps":1.779999,"marketStatus":"Not Yet Opened","change":-0.33,"latestTime":"04-21 16:00:00 EDT","open":78.89,"high":79.57,"low":77.63,"amount":83800689.96418,"amplitude":0.024541,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":1.779999,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1745308800000},"marketStatusCode":0,"adr":0,"adrRate":0,"listingDate":766296000000,"exchange":"NYSE","adjPreClose":79.05,"dividendRate":0.03811,"preHourTrading":{"tag":"盘前","latestPrice":78.9415,"preClose":79.05,"latestTime":"09:23 EDT","volume":128,"amount":10087.82976,"timestamp":1745241813691},"postHourTrading":{"tag":"盘后","latestPrice":78.72,"preClose":78.72,"latestTime":"19:20 EDT","volume":48608,"amount":3826415.71,"timestamp":1745277610225},"volumeRatio":0.798707,"impliedVol":0.2499,"impliedVolPercentile":0.824},"requestUrl":"/m/hq/s/ADC/wiki","defaultTab":"wiki","newsList":[{"id":"2529689806","title":"Trodelvy® Plus Keytruda® Demonstrates a Statistically Significant and Clinically Meaningful Improvement in Progression Free Survival in Patients With Previously Untreated PD-L1+ Metastatic Triple-Negative Breast Cancer","url":"https://stock-news.laohu8.com/highlight/detail?id=2529689806","media":"Business Wire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529689806?lang=en_us&edition=full_marsco","pubTime":"2025-04-21 20:30","pubTimestamp":1745238600,"startTime":"0","endTime":"0","summary":"– The First Pivotal Phase 3 Trial to Demonstrate Superiority of a TROP-2 Antibody-Drug Conjugate, Trodelvy, Plus Keytruda Versus Standard of Care Keytruda plus Chemotherapy in 1L mTNBC –。– Trodelvy Plus Keytruda Shows an Early Trend in Improvement for Overall Survival Versus Standard of Care in Patients with Previously Untreated PD-L1+  mTNBC –。\"These findings are the first to show the transformative potential of an antibody-drug conjugate combined with an immuno-oncology agent in early treatment lines of metastatic breast cancer,\" said Dietmar Berger, MD, PhD, Chief Medical Officer, Gilead Sciences. \"For patients with this difficult to treat type of breast cancer, these results potentially offer a new pathway that may redefine their treatment options.\". The significant and meaningful improvement in PFS demonstrated in ASCENT-04 further reinforces the potential of Trodelvy plus Keytruda as a much-needed new treatment option for patients with previously untreated inoperable  PD-L1+ loca","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/trodelvy-plus-keytruda-demonstrates-statistically-123000256.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["SAR","LU1585245621.USD","IE00BKVL7J92.USD","LU0861579265.USD","IE00BJT1NW94.SGD","LU2087621335.USD","IE00BZ1G4Q59.USD","BK4585","LU0985320562.USD","LU0109394709.USD","LU1069347547.HKD","MCBS","ADC","LU2023250843.SGD","SG9999001176.USD","LU0106261372.USD","CINV","GILD","LU1162221912.USD","SG9999014542.SGD","PFS","ORR","BK4578","LU0965508806.USD","LU1023059063.AUD","LU0203347892.USD","IE00BSNM7G36.USD","BK4203","SG9999002232.USD","BK4007","LU2106854487.HKD","LU0208291251.USD","SG9999002224.SGD","LU1035773651.USD","HR","LU0965509283.SGD","IE00B1BXHZ80.USD","IE00BBT3K403.USD","LU0265550359.USD","LU1066051225.USD","LU2112291526.USD","LU2361045086.USD","LU1093756325.SGD","LU0234570918.USD","PD","MRK","OS","LU0203345920.USD","LU0234572021.USD","IE000M9KFDE8.USD"],"gpt_icon":0},{"id":"2529803706","title":"AstraZeneca- Daiichi Sankyo's Multi-Billion Dollar Cancer Drug Shows Superior Efficacy Across Broad HER2 Positive Metastatic Breast Cancer Patients","url":"https://stock-news.laohu8.com/highlight/detail?id=2529803706","media":"Benzinga","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529803706?lang=en_us&edition=full_marsco","pubTime":"2025-04-21 20:05","pubTimestamp":1745237101,"startTime":"0","endTime":"0","summary":"AstraZeneca Plc  on Monday released topline data from the DESTINY-Breast09 Phase 3 trial ofEnhertu either alone or in combination with pertuzumab versus standard of care THP  as a first-line treatment in patients with HER2-positive metastatic breast cancer.High-level results from a planned interim analysis showed Enhertu pertuzumab combination demonstrated a statistically significant and clinically meaningful improvement in progression-free survival  compared to THP.Also Read: European Drug Regulator Approves AstraZeneca’s Two Flagship Cancer Drugs For Breast And Lung Cancer Settings. HER2-positive metastatic breast cancer is an aggressive disease driven by overexpression or amplification of HER2, affecting 15-20% of patients with metastatic breast cancer.While HER2-targeted therapies have improved outcomes, prognosis remains poor, with most patients experiencing disease progression within two years of 1st-line treatment with THP, which has been the standard of care for more than a dec","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/astrazeneca-daiichi-sankyos-multi-billion-120501820.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4585","BK4007","LU2417539215.USD","BK4568","BK4211","OS","BK4080","LU2236285917.USD","ADC","BK4195","DSKYF","AZN","LU0109394709.USD","LU0320765992.SGD","DSNKY","LU1829250122.USD","LU2456880835.USD","BK4097","LU0889565916.HKD","BK4231","BK4588","LU2462157665.USD","PFS"],"gpt_icon":0},{"id":"2529803700","title":"ENHERTU® (fam-trastuzumab deruxtecan-nxki) plus pertuzumab demonstrated highly statistically significant and clinically meaningful improvement in progression-free survival vs. THP as 1st-line therapy for patients with HER2+ metastatic breast cancer","url":"https://stock-news.laohu8.com/highlight/detail?id=2529803700","media":"Business Wire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529803700?lang=en_us&edition=full_marsco","pubTime":"2025-04-21 19:00","pubTimestamp":1745233200,"startTime":"0","endTime":"0","summary":"DESTINY-Breast09 Phase III trial of AstraZeneca and Daiichi Sankyo’s ENHERTU is the first trial in more than a decade to demonstrate superior efficacy across a broad HER2-positive metastatic patient population versus current 1st-line standard of care. WILMINGTON, Del., April 21, 2025----Positive high-level results from a planned interim analysis of the DESTINY-Breast09 Phase III trial showed ENHERTU  in combination with pertuzumab demonstrated a highly statistically significant and clinically meaningful improvement in progression-free survival  compared to a taxane, trastuzumab and pertuzumab  as a 1st-line treatment for patients with HER2-positive metastatic breast cancer.The PFS improvement was seen across all pre-specified patient subgroups with ENHERTU in combination with pertuzumab. The key secondary endpoint of overall survival  was not mature at the time of this planned interim analysis; however, interim OS data showed an early trend favoring the ENHERTU combination compared wit","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/enhertu-fam-trastuzumab-deruxtecan-nxki-110000627.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4588","AZN","BK4080","BK4097","OS","ADC","LU0109394709.USD","BK4585","LU1829250122.USD","HR","BK4195","PFS","LU2456880835.USD","BK4007","BK4225","LU0320765992.SGD","LU2417539215.USD","LU2462157665.USD","BK4211","BK4203","BK4231","BK4568","LU2236285917.USD","LU0889565916.HKD"],"gpt_icon":0},{"id":"2528011955","title":"Agree Realty Corp  expected to post earnings of 42 cents a share - Earnings Preview","url":"https://stock-news.laohu8.com/highlight/detail?id=2528011955","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2528011955?lang=en_us&edition=full_marsco","pubTime":"2025-04-19 04:41","pubTimestamp":1745008865,"startTime":"0","endTime":"0","summary":"Agree Realty Corp  expected to post earnings of42cents a share - Earnings Preview Agree Realty Corp ADC.N, ADC is expected to show a rise in quarterly revenue when it reports  results on April 22 for ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250418:nL8N3QW0UH:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ADC"],"gpt_icon":0},{"id":"2528064931","title":"AI Says I Have The Face of a Celebrity. Humans Don't Seem to Agree. -- WSJ","url":"https://stock-news.laohu8.com/highlight/detail?id=2528064931","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2528064931?lang=en_us&edition=full_marsco","pubTime":"2025-04-18 21:30","pubTimestamp":1744983000,"startTime":"0","endTime":"0","summary":"When AI steals all the jobs, it's clear what will be left: celebrities. Also, welders, roofers, mechanics, home health aides, masons and beekeepers. But celebrity seems more attainable for me.So when I opened my favorite academic journal for marketing, the Journal for Marketing Research , and saw a paper titled, \"An AI Method to Score Celebrity Visual Potential,\" I knew I had to get my celebrity visual potential checked. If it went well, I could become an influencer and avoid the sting of getting rejected, or accepted, by beekeeper school.They fed the photos to an AI algorithm, asking it to discover the facial characteristics that separated the two groups. They set the minimum score for a celebrity at 0.5. Anything below cut off and you are doomed to a real job and as few as one spouse for your entire life.Feng wrote, \"Your Celebrity Visual Potential  score is impressively high, exceeding 0.8. Your high CVP score is mainly boosted by your prominent cheekbones, large eyes and narrow fac","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4231","ADC","BK4080"],"gpt_icon":0},{"id":"2528452051","title":"Calendar of U.S. Earnings Expected in the Week Ahead","url":"https://stock-news.laohu8.com/highlight/detail?id=2528452051","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2528452051?lang=en_us&edition=full_marsco","pubTime":"2025-04-18 18:00","pubTimestamp":1744970400,"startTime":"0","endTime":"0","summary":"Major companies tentatively scheduled to report quarterly earnings in the week ahead, with earnings estimates provided by FactSet Research Systems Inc.·Bank of Hawaii Corp                              1Q       .89       BMO. ·W. R. Berkley Corp                               1Q       .98       AMC. ·Baker Hughes Co                                  1Q       .47   5:00 PM. ·Capital One Fncl                                 1Q      3.64   4:05 PM","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CME","IVZ","MCB","VBTX","ENPH","HBCP","CATY","ARR","BANC","HBT","WAL","AMED","BOH","UCB","BKR","CLB","BMRN","AZZ","ASR","CCS","CVBF","ELV","CACI","WRB","COFS","HAFC","COF","ONB","CB","CYH","AGNC","MEDP","T","RNST","TRMK","FIX","ALK","BSX","PEBO","ADC","MCRI","PEGA","ZWS","CCB","GPC","RRC","NBHC","CALX","PFSI"],"gpt_icon":1},{"id":"2528704927","title":"MEL, LaSalle LOGIPORT REIT Agree to Explore Securitization Deal","url":"https://stock-news.laohu8.com/highlight/detail?id=2528704927","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2528704927?lang=en_us&edition=full_marsco","pubTime":"2025-04-18 09:40","pubTimestamp":1744940425,"startTime":"0","endTime":"0","summary":"Mitsubishi Estate Logistics REIT  and LaSalle LOGIPORT REIT  signed an agreement to explore the securitization of properties they co-own, according to a Thursday filing on the Tokyo Stock Exchange.Under the plan, the two firms may transfer joint co-ownership interests in assets such as LOGIPORT Sagamihara, Hashimoto, Osaka Taisho, and Kawasaki Bay to a special purpose company , in which they could also invest.The move would allow both REITs to realise capital gains while maintaining indirect asset exposure.No final decision has been made, and there is no guarantee the transaction will proceed.Price : $139200.00, Change: $+300, Percent Change: +0.22%","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4080","CFA.SI","ADC","SPC","REIT","JPY","BK4231"],"gpt_icon":0},{"id":"2528271779","title":"Agree Realty (ADC): Among Mid- And Large-Cap Stocks Insiders Are Buying After Trump’s Tariff Rollout","url":"https://stock-news.laohu8.com/highlight/detail?id=2528271779","media":"Insider Monkey","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2528271779?lang=en_us&edition=full_marsco","pubTime":"2025-04-17 03:09","pubTimestamp":1744830599,"startTime":"0","endTime":"0","summary":"We recently published a list of 19 Mid- And Large-Cap Stocks Insiders Are Buying After Trump’s Tariff Rollout. In this article, we are going to take a look at where Agree Realty Corporation  stands against other mid- and large-cap stocks insiders are buying after Trump’s tariff rollout.On April 2, 2025, President Donald Trump declared “Liberation Day” and signed Executive Order 14257, imposing a baseline 10% tariff on nearly all U.S. imports, effective April 5. Higher tariffs—ranging from 11% to 50%—were scheduled for 57 countries and territories, including the European Union, China, and Japan. These increased rates were set to begin April 9 but were postponed for 90 days, with the exception of China, which continued to face elevated tariffs.In April, some insiders took advantage of the dip to buy shares, while others chose to sell. Analyzing insider trading can provide valuable insights: purchases often signal confidence in the company’s future, while sales may reflect personal or div","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/agree-realty-adc-among-mid-190959988.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4080","BK4231","ADC"],"gpt_icon":0},{"id":"2527537242","title":"Countdown to Agree Realty (ADC) Q1 Earnings: A Look at Estimates Beyond Revenue and EPS","url":"https://stock-news.laohu8.com/highlight/detail?id=2527537242","media":"Zacks","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2527537242?lang=en_us&edition=full_marsco","pubTime":"2025-04-16 21:15","pubTimestamp":1744809318,"startTime":"0","endTime":"0","summary":"Analysts on Wall Street project that Agree Realty  will announce quarterly earnings of $1.04 per share in its forthcoming report, representing an increase of 1% year over year. Revenues are projected to reach $166 million, increasing 11.1% from the same quarter last year.The consensus EPS estimate for the quarter has been revised 0.3% lower over the last 30 days to the current level. This reflects how the analysts covering the stock have collectively reevaluated their initial estimates during this timeframe.Ahead of a company's earnings disclosure, it is crucial to give due consideration to changes in earnings estimates. These revisions serve as a noteworthy factor in predicting potential investor reactions to the stock. Numerous empirical studies consistently demonstrate a strong relationship between trends in earnings estimate revision and the short-term price performance of a stock.While investors typically rely on consensus earnings and revenue estimates to gauge how the business m","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/countdown-agree-realty-adc-q1-131518748.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["ADC"],"gpt_icon":0},{"id":"2527978213","title":"Press Release: Akari Therapeutics Reports Full Year 2024 Financial Results and Provides Corporate Update","url":"https://stock-news.laohu8.com/highlight/detail?id=2527978213","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2527978213?lang=en_us&edition=full_marsco","pubTime":"2025-04-16 20:00","pubTimestamp":1744804800,"startTime":"0","endTime":"0","summary":"Advancing development of next-generation precision Antibody Drug Conjugates  to address multiple indications across a range of cancer types. Continued progress of lead program, AKTX-101, for the treatment of solid tumors. Platform technology to fuel pipeline with ability to generate novel. Leveraging opportunities for non-dilutive capital through partnering of legacy pipeline. Cash on hand expected to be sufficient to fund planned operations into September 2025. BOSTON and LONDON, April 16, 2025  -- Akari Therapeutics, Plc , a biotechnology company developing next-generation precision bi-functional antibody drug conjugates  for the treatment of cancer, today reported its financial results for the fiscal year ended December 31, 2024 and provided a corporate update.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CPI","BK4007","AKTX","BK4139","LENZ","ADC","BK4231","BK4080"],"gpt_icon":0},{"id":"2527044841","title":"MetLife Investment, Equitable, New York Life Agree to $700 Million Forward-Flow Facility for Octane","url":"https://stock-news.laohu8.com/highlight/detail?id=2527044841","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2527044841?lang=en_us&edition=full_marsco","pubTime":"2025-04-15 22:13","pubTimestamp":1744726388,"startTime":"0","endTime":"0","summary":"MetLife  Investment Management and Equitable , along with lead investor New York Life, have agreed to a forward-flow facility for fintech firm Octane of up to $700 million.New York Life, Metlife Investment, and Equitable have agreed to fund up to $350 million, $200 million, and $150 million, respectively, of fixed-rate installment powersports loans originated by Octane's in-house lender Roadrunner Financial, Octane said in a statement Tuesday.Octane said the proceeds of the deal will support its \"continued momentum\" as it grew 2024 originations by 36% year over year.Price: 73.75, Change: +0.80, Percent Change: +1.10","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU1291159041.SGD","BK4202","BK4231","EQH","BK4162","LU1989771016.USD","BK4080","ADC","BK4588","LU2355687059.USD","BK4184","BK4585","LU1989772923.USD","LU1496350502.SGD","BK4145","BK4561","LU1989772840.SGD","MET","FORD"],"gpt_icon":0},{"id":"2527667079","title":"Indonesia, Turkey Agree on Cultural Partnerships","url":"https://stock-news.laohu8.com/highlight/detail?id=2527667079","media":"Tempo","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2527667079?lang=en_us&edition=full_marsco","pubTime":"2025-04-13 19:56","pubTimestamp":1744545366,"startTime":"0","endTime":"0","summary":"TEMPO.CO, Jakarta --Indonesia and Turkey inked several MoUs on cultural exchange programs, as confirmed by Minister of Culture Fadli Zon in an official statement on Sunday, April 13, 2025. “During our meeting, the Ministry of Culture and Tourism of Turkey, represented by Mehmet Nuri Ersoy, agreed to sign MoUs for cooperation,” said Fadli Zon.The MoU was part of Prabowo’s visit to Turkey, since April 10. Fadli said the exchange program will include history, literature, capacity building, film, and various cultural expressions.“For example, artifacts from Turkey can be exhibited in Indonesia, and vice versa,” said Fadli.","market":"sg","thumbnail":"https://statik.tempo.co/data/2025/03/09/id_1383246/1383246_720.jpg","type":0,"news_type":0,"thumbnails":["https://statik.tempo.co/data/2025/03/09/id_1383246/1383246_720.jpg"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://en.tempo.co/read/1996345/indonesia-turkey-agree-on-cultural-partnerships","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tempo_highlight","symbols":["BK4231","BK4080","ADC"],"gpt_icon":0},{"id":"2526566923","title":"JX Energy, Lender Agree on Repayment Options for $1.5 Million Loan","url":"https://stock-news.laohu8.com/highlight/detail?id=2526566923","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2526566923?lang=en_us&edition=full_marsco","pubTime":"2025-04-11 20:48","pubTimestamp":1744375680,"startTime":"0","endTime":"0","summary":"JX Energy  shared an update regarding the payment of the outstanding $1.5 million loan under an agreement entered March 19, stating it will settle the amount in cash, through a share issue, or both, a Thursday filing with the Hong Kong bourse said.The loan, granted to the company by Liu Zhixue in March, is falling due Dec. 10.If the parties agree on a share issue for settlement, the loan is convertible into around 58,932,088 shares at HK$0.20 apiece.The shares represent 10.13% of the oil and gas exploration company's enlarged issued share capital.Price : $0.08, Change: $+0.0080, Percent Change: +10.53%","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["HKD","BK4588","BK1238","ADC","03395","BK4526","BK4585","BK4231","BK4023","BK4080"],"gpt_icon":0},{"id":"2526724485","title":"Most Shareholders Will Probably Agree With Bank of Tianjin Co., Ltd.'s (HKG:1578) CEO Compensation","url":"https://stock-news.laohu8.com/highlight/detail?id=2526724485","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2526724485?lang=en_us&edition=full_marsco","pubTime":"2025-04-11 06:45","pubTimestamp":1744325111,"startTime":"0","endTime":"0","summary":"Key Insights Bank of Tianjin to hold its Annual General Meeting on 17th of April CEO Hongtao Wu's total compensation...","market":"nz","thumbnail":"https://images.simplywall.st/asset/industry/7013000-choice2-main-header/1585186648241","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/7013000-choice2-main-header/1585186648241"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/hk/banks/hkg-1578/bank-of-tianjin-shares/news/most-shareholders-will-probably-agree-with-bank-of-tianjin-c","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK1560","BK4231","01578","ADC","BK1235","BK4080"],"gpt_icon":0},{"id":"2526610544","title":"BRIEF-Agree Realty Declares Increased Monthly Common Dividend","url":"https://stock-news.laohu8.com/highlight/detail?id=2526610544","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2526610544?lang=en_us&edition=full_marsco","pubTime":"2025-04-11 04:49","pubTimestamp":1744318153,"startTime":"0","endTime":"0","summary":"BRIEF-Agree Realty Declares Increased Monthly Common DividendAgree Realty Corp ADC.N:AGREE REALTY DECLARES INCREASED MONTHLY COMMON DIVIDENDAGREE REALTY CORP - DECLARES MONTHLY CASH DIVIDEND OF $0.256 PER COMMON SHARESource text: ID:nPn3th7gkaFurther company coverage: ADC.N","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250410:nTUA3VZTXC:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ADC","BK4080","BK4231"],"gpt_icon":0},{"id":"2526493495","title":"Agree Realty Increases Monthly Dividend to $0.256 Per Share, Payable May 14 to Holders of Record April 30","url":"https://stock-news.laohu8.com/highlight/detail?id=2526493495","media":"MT Newswires Live","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2526493495?lang=en_us&edition=full_marsco","pubTime":"2025-04-11 04:12","pubTimestamp":1744315965,"startTime":"0","endTime":"0","summary":"Agree Realty Increases Monthly Dividend to $0.256 Per Share, Payable May 14 to Holders of Record April 30","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4080","ADC","BK4231"],"gpt_icon":0},{"id":"2526116549","title":"Agree Realty increases monthly common dividend 1.2% to 25.6c per share","url":"https://stock-news.laohu8.com/highlight/detail?id=2526116549","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2526116549?lang=en_us&edition=full_marsco","pubTime":"2025-04-11 04:10","pubTimestamp":1744315833,"startTime":"0","endTime":"0","summary":"Agree Realty (ADC) has declared a monthly cash dividend of 25.6c per common share, representing a 1.2% month-over-month increase. The dividend is p...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/agree-realty-increases-monthly-common-dividend-1-2-to-25-6c-per-share?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/agree-realty-increases-monthly-common-dividend-1-2-to-25-6c-per-share?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4231","ADC","BK4080"],"gpt_icon":0},{"id":"2526546078","title":"Agree Realty Declares Increased Monthly Common Dividend","url":"https://stock-news.laohu8.com/highlight/detail?id=2526546078","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2526546078?lang=en_us&edition=full_marsco","pubTime":"2025-04-11 04:05","pubTimestamp":1744315501,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250410:nTUA3VZTXC:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["ADC","BK4080","BK4231"],"gpt_icon":0},{"id":"2526546017","title":"Press Release: Agree Realty Declares Increased Monthly Common Dividend","url":"https://stock-news.laohu8.com/highlight/detail?id=2526546017","media":"Dow Jones","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2526546017?lang=en_us&edition=full_marsco","pubTime":"2025-04-11 04:05","pubTimestamp":1744315500,"startTime":"0","endTime":"0","summary":"ROYAL OAK, Mich., April 10, 2025 /PRNewswire/ -- Agree Realty Corporation   today announced that its Board of Directors has authorized, and the Company has declared, a monthly cash dividend of $0.256 per common share, representing a 1.2% month-over-month increase. The monthly dividend reflects an annualized dividend amount of $3.072 per common share, representing a 2.4% increase over the annualized dividend amount of $3.00 per common share from the second quarter of 2024. The dividend is payable May 14, 2025 to stockholders of record at the close of business on April 30, 2025.Additionally, the Company's Board of Directors has authorized, and the Company has declared, a monthly cash dividend on its 4.25% Series A Cumulative Redeemable Preferred Stock of $0.08854 per depositary share, which is equivalent to $1.0625 per annum. The dividend is payable May 1, 2025 to stockholders of record at the close of business on April 21, 2025.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ADC","BK4231","BK4080"],"gpt_icon":0},{"id":"2526550198","title":"OS Therapies Announces Positive Data for OST-HER2 in the Treatment of Unresected Osteosarcoma in Dogs Opening the Potential for Use as Front-Line Therapy in Humans","url":"https://stock-news.laohu8.com/highlight/detail?id=2526550198","media":"Business Wire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2526550198?lang=en_us&edition=full_marsco","pubTime":"2025-04-10 19:42","pubTimestamp":1744285320,"startTime":"0","endTime":"0","summary":"Yet to be published data from clinical study combining OST-HER2 with palliative radiation in dogs with unresected, primary osteosarcoma shows clinical and radiographic arrest of the primary tumor, delayed pulmonary metastases and prolonged overall survival of greater than 500 days in 5 out of 15 dogs.Data from new publication in the journal \"Molecular Therapy\" show OST-HER2 induces strong innate and cytotoxic immune responses beginning at the 1st dose of 3 dose regimen, that correlate with prevention of metastasis and long-term survival in dogs with resected primary osteosarcoma.Additionally, the Company announced the publication of positive data in the journal \"Molecular Therapy\" entitled \"Immunological responses and clinical outcomes in dogs with osteosarcoma receiving standard therapy and a Listeria vaccine expressing HER2\" demonstrated the correlation of innate and adaptive immune responses to OST-HER2, with prevention of metastasis and long-term survival benefit when used in the a","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/os-therapies-announces-positive-data-114200323.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4195","BK4211","PFS","BK4080","OSTX","DC","BK4231","BK4139","BK4017","OST","BK4148","ADC"],"gpt_icon":1}],"profile":{"websiteUrl":"http://www.agreerealty.com","stockEarnings":[{"period":"1week","weight":0.0278},{"period":"1month","weight":0.0431},{"period":"3month","weight":0.0759},{"period":"6month","weight":0.0266},{"period":"1year","weight":0.3918},{"period":"ytd","weight":0.1174}],"compareEarnings":[{"period":"1week","weight":-0.0468},{"period":"1month","weight":-0.0888},{"period":"3month","weight":-0.1479},{"period":"6month","weight":-0.1109},{"period":"1year","weight":0.0378},{"period":"ytd","weight":-0.1232}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"Agree Realty Corporation (the Company), a Maryland corporation, is a fully integrated real estate investment trust (REIT) primarily focused on the ownership, acquisition, development and management of retail properties net leased to industry leading tenants. The Company was founded in 1971 by its current Executive Chairman, Richard Agree, and its common stock was listed on the New York Stock Exchange in 1994. As of March 31, 2024, the Company owned 2,161 properties, with a total gross leasable area (GLA) of approximately 44.9 million square feet.","yearOnYearQuotes":[{"month":1,"riseRate":0.580645,"avgChangeRate":-0.003784},{"month":2,"riseRate":0.451613,"avgChangeRate":-0.001428},{"month":3,"riseRate":0.580645,"avgChangeRate":0.015289},{"month":4,"riseRate":0.580645,"avgChangeRate":0.003259},{"month":5,"riseRate":0.516129,"avgChangeRate":0.017098},{"month":6,"riseRate":0.677419,"avgChangeRate":0.011409},{"month":7,"riseRate":0.677419,"avgChangeRate":0.024183},{"month":8,"riseRate":0.451613,"avgChangeRate":0.001804},{"month":9,"riseRate":0.483871,"avgChangeRate":-0.005771},{"month":10,"riseRate":0.548387,"avgChangeRate":-0.001244},{"month":11,"riseRate":0.645161,"avgChangeRate":0.002723},{"month":12,"riseRate":0.483871,"avgChangeRate":0.011628}],"exchange":"NYSE","name":"Agree","nameEN":"Agree"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.33.2","shortVersion":"4.33.2","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Agree(ADC),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Agree(ADC) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Agree,ADC,Agree股票,Agree股票老虎,Agree股票老虎国际,Agree行情,Agree股票行情,Agree股价,Agree股市,Agree股票价格,Agree股票交易,Agree股票购买,Agree股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Agree(ADC),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Agree(ADC) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}

Introduction